Aquestive Therapeutics, Inc. (AQST)
NASDAQ: AQST · Real-Time Price · USD
4.290
+0.070 (1.66%)
At close: Mar 9, 2026, 4:00 PM EDT
4.210
-0.080 (-1.86%)
After-hours: Mar 9, 2026, 7:58 PM EDT
Aquestive Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -83.78 | -44.14 | -7.87 | -54.41 | -70.54 | |
| Depreciation & Amortization | 0.57 | 0.74 | 1.37 | 2.55 | 3.15 | |
| Other Amortization | 11 | 10.71 | 1.97 | 0.22 | 3.73 | |
| Stock-Based Compensation | 7.62 | 7.1 | 2.69 | 4.38 | 6.82 | |
| Other Operating Activities | -0.03 | -0.22 | 0.8 | 5.46 | 25.59 | |
| Change in Accounts Receivable | -10.37 | 1.09 | -3.07 | 7.35 | -5.35 | |
| Change in Inventory | -0.13 | 0.73 | -0.99 | -1.74 | -1.58 | |
| Change in Accounts Payable | 19.52 | 2.78 | -1.02 | 1.63 | 1.23 | |
| Change in Unearned Revenue | -0.57 | -12.84 | 0.97 | 25.04 | 3.56 | |
| Change in Other Net Operating Assets | 3.73 | -1.72 | -1.23 | -0.31 | 0.41 | |
| Operating Cash Flow | -52.43 | -35.76 | -6.38 | -9.82 | -32.98 | |
| Capital Expenditures | -0.56 | -0.16 | -1 | -1.02 | -0.91 | |
| Sale (Purchase) of Intangibles | - | - | - | -1.5 | - | |
| Investing Cash Flow | -0.56 | -0.16 | -1 | -2.52 | -0.91 | |
| Long-Term Debt Issued | - | - | 31.14 | - | - | |
| Long-Term Debt Repaid | -0.03 | -0.02 | -51.53 | - | - | |
| Net Debt Issued (Repaid) | -0.03 | -0.02 | -20.39 | - | - | |
| Issuance of Common Stock | 103.46 | 84.72 | 17.26 | 13.62 | 30.12 | |
| Repurchase of Common Stock | -0.81 | -1.1 | -0.01 | -0 | -0.01 | |
| Other Financing Activities | -0.01 | -0.01 | 7.11 | -2.03 | - | |
| Financing Cash Flow | 102.62 | 83.59 | 3.97 | 11.59 | 30.11 | |
| Net Cash Flow | 49.62 | 47.67 | -3.4 | -0.75 | -3.78 | |
| Free Cash Flow | -52.99 | -35.92 | -7.38 | -10.84 | -33.89 | |
| Free Cash Flow Margin | -118.97% | -62.40% | -14.58% | -22.74% | -66.67% | |
| Free Cash Flow Per Share | -0.50 | -0.41 | -0.12 | -0.22 | -0.89 | |
| Cash Interest Paid | 6.1 | 7.1 | 4.6 | 6.44 | 6.44 | |
| Cash Income Tax Paid | -0.07 | 0.31 | - | - | - | |
| Levered Free Cash Flow | -29.24 | -10.49 | -16.22 | -21.29 | -28.1 | |
| Unlevered Free Cash Flow | -29.54 | -10.7 | -13.53 | -13.73 | -17.8 | |
| Change in Working Capital | 12.18 | -9.96 | -5.34 | 31.98 | -1.73 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.